Bioequivalence and Safety of Two Amisulpride Formulations in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‑Label, Single‑Dose, Crossover Study
The test and reference amisulpride formulations were bioequivalent under fasting and fed conditions. Both formulations showed similar safety and tolerability in the population studied.
Authors
- Ronghui Du (ORCID: https://orcid.org/0000-0002-3189-0515)
- Peng Yu (ORCID: https://orcid.org/0000-0002-3011-3837)
- Zhixiang Pan (ORCID: https://orcid.org/0000-0002-0715-8973)
- Min Wang (ORCID: https://orcid.org/0000-0002-5160-7852)
- Guan Liu (ORCID: https://orcid.org/0000-0001-7761-9512)
- Hegui Yan (ORCID: https://orcid.org/0009-0006-6019-7281)
Institutions
- Wuhan Pulmonary Hospital (CN)
Publication Details
- Journal
- Drugs in R&D
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1007/s40268-025-00508-7
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00